t(11;14)多发性骨髓瘤及其BCL2依赖性的整合表观遗传与转录单细胞分析
该研究在初诊多发性骨髓瘤样本中整合单细胞ATAC-seq与RNA-seq,解析t(11;14)多发性骨髓瘤的表观遗传调控组与转录组。t(11;14)多发性骨髓瘤富集B细胞样表观遗传特征,维奈克拉耐药时该特征丢失并获得经典浆细胞转录因子。MCL1与BCL2L1拷贝数增加及结构重排与维奈克拉耐药相关。
要点
- t(11;14)多发性骨髓瘤富集B细胞样表观遗传特征,提示其与B细胞而非浆细胞生物学相关。
- 维奈克拉耐药时B细胞样表观遗传特征丢失,并获得经典浆细胞转录因子。
- MCL1和BCL2L1拷贝数增加及结构重排与t(11;14)多发性骨髓瘤患者维奈克拉耐药相关。
核心结论
- t(11;14)多发性骨髓瘤具有B细胞样表观遗传特征,维奈克拉耐药伴随该特征丢失及MCL1、BCL2L1拷贝数增加或结构重排。
研究设计与样本
- 在初诊多发性骨髓瘤样本中整合单细胞ATAC-seq与单细胞RNA-seq分析。
主要发现
- t(11;14)多发性骨髓瘤富集B细胞样表观遗传特征,确认其系统发育上与B细胞而非浆细胞生物学相关。
- 维奈克拉耐药时观察到B细胞样表观遗传特征丢失,并获得经典浆细胞转录因子。
- MCL1和BCL2L1拷贝数增加及结构重排与t(11;14)多发性骨髓瘤患者维奈克拉耐药相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The translocation t(11;14) occurs in 20% of patients with multiple myeloma (MM) and results in the upregulation of CCND1. Nearly two-thirds of t(11;14) MM cells are BCL2 primed and highly responsive to the oral BCL2 inhibitor venetoclax. Although it is evident that this unique sensitivity to venetoclax depends on the Bcl-2 homology domain 3- proapoptotic protein priming of BCL2, the biology underlying t(11;14) MM dependency on BCL2 is poorly defined. Importantly, the epigenetic regulation of t(11;14) transcriptomes and its impact on gene regulation and clinical response to venetoclax remain elusive. In this study, by integrating assay for transposase-accessible chromatin by sequencing (ATAC-seq) and RNA-seq at the single-cell level in primary MM samples, we have defined the epigenetic regulome and transcriptome associated with t(11;14) MM. A B-cell-like epigenetic signature was enriched in t(11;14) MM, confirming its phylogeny link to B-cell rather than plasma cell biology. Of note, a loss of a B-cell-like epigenetic signature with a gain of canonical plasma cell transcription factors was observed at the time of resistance to venetoclax. In addition, MCL1 and BCL2L1 copy number gains and structural rearrangements were linked to venetoclax resistance in patients with t(11;14) MM. To date, this is the first study in which both single-cell (sc) ATAC-seq and scRNA-seq analysis are integrated into primary MM cells to obtain a deeper resolution of the epigenetic regulome and transcriptome associated with t(11;14) MM biology and venetoclax resistance.
引用
- Leblay N, Ahn S, Tilmont R, et al. Integrated epigenetic and transcriptional single-cell analysis of t(11;14) multiple myeloma and its BCL2 dependency. Blood. 2024. PMID: 37729611. doi:10.1182/blood.2023020276
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。